SCHEMBL5183860

SCHEMBL5183860

CCc1ccc(-c2[nH]ccc2-c2cccc(C(=O)O)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 1/20 0.50
▸ FOLH1 Q04609 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.46
▸ PLA2G2A P14555 1/20 0.44
▸ KMO O15229 1/20 0.44
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ AKR1C3 P42330 3/20 0.43
▸ AKR1C2 P52895 3/20 0.43
▸ DHFR P00374 1/20 0.43
▸ PTGER1 P34995 1/20 0.42
▸ FABP3 P05413 1/20 0.42
▸ FABP4 P15090 1/20 0.42
▸ FABP5 Q01469 1/20 0.42
▸ LTB4R2 Q9NPC1 1/20 0.42
▸ PTPN11 Q06124 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13756311 0.82 BCL2 (0.71) BCL2ALDH1A1KMORXRARXRB
SCHEMBL10243325 0.82 BCL2 (0.71) BCL2ALDH1A1KMORXRARXRB
SCHEMBL12894987 0.75 BCL2 (0.78) BCL2FOLH1KMORXRARXRB
SCHEMBL12171780 0.73 NPC1 (0.60) BCL2ALDH1A1
SCHEMBL31660297 0.73 CA12 (0.47) BCL2FOLH1ALDH1A1KMORXRA
SCHEMBL26096390 0.73 CA12 (0.47) BCL2FOLH1ALDH1A1KMORXRA
SCHEMBL28369469 0.73 BCL2 (0.75) BCL2FOLH1ALDH1A1KMORXRA
SCHEMBL26365859 0.72 FOLH1 (0.62) BCL2FOLH1PLA2G2AKMORXRA
SCHEMBL28375431 0.71 BCL2 (0.73) BCL2FOLH1ALDH1A1KMORXRA
SCHEMBL60690 0.71 NPC1 (0.63) BCL2ALDH1A1DHFRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799207-A2 PYRAZOLE OR TRIAZOLE COMPOUNDS AND THEIR USE FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING SOMATIC MUTATION-RELATED DISEASES PTC Therapeutics, Inc. (US) 2007-06-27 — — EP disclosed
WO-2006044502-A2 PYRAZOLE OR TRIAZOLE COMPOUNDS AND THEIR USE FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING SOMATIC MUTATION-RELATED DISEASES PTC THERAPEUTICS, INC. (US) 2006-04-27 — — WO disclosed
Send feedback